Alzheimer's Drug Discovery Foundation
Overview
Alzheimer's Drug Discovery Foundation is a non-profit venture philanthropy firm that funds drug discovery and development for Alzheimer's disease and related dementias.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Alamar Biosciences | Jan 2025 | Grant | Lead |
| AviadoBio | Mar 2026 | Grant | Co-investor |
| LEXEO Therapeutics | Jan 2021 | Series A | Co-investor |
| CuraSen Therapeutics, Inc. | Oct 2023 | Grant | Co-investor |
| MindImmune Therapeutics, Inc. | Mar 2026 | Convertible Debt | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Alzheimer's Drug Discovery Foundation based?
Alzheimer's Drug Discovery Foundation is headquartered in New York City, New York, United States.
When was Alzheimer's Drug Discovery Foundation founded?
Alzheimer's Drug Discovery Foundation was founded in 1998.
How many portfolio companies does Alzheimer's Drug Discovery Foundation have?
Alzheimer's Drug Discovery Foundation has 56 portfolio companies in Caplight's dataset.
What are some companies in Alzheimer's Drug Discovery Foundation's portfolio?
Portfolio companies visible on Caplight include Alamar Biosciences, AviadoBio, LEXEO Therapeutics, CuraSen Therapeutics, Inc., MindImmune Therapeutics, Inc..
What was Alzheimer's Drug Discovery Foundation's most recent investment shown here?
Alzheimer's Drug Discovery Foundation's most recent investment in this portfolio sample was in AviadoBio in 2026.
What sectors does Alzheimer's Drug Discovery Foundation focus on?
Alzheimer's Drug Discovery Foundation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Consumer & Commerce, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software.
What company stages does Alzheimer's Drug Discovery Foundation focus on?
Alzheimer's Drug Discovery Foundation typically invests at the MultiStage stage.
What is Alzheimer's Drug Discovery Foundation's AUM?
Alzheimer's Drug Discovery Foundation's assets under management are estimated between $324.0M and $324.0M.